Table 6.
Symptom reporting by the patients at the start of treatment, assessed via the EORTC QLQ-C30 and the EORTC QLQ-BR23
| Symptoms | Mean score |
|---|---|
| Breast symptoms (n = 3,948) | 28.81 |
| Arm symptoms (n = 3,942) | 29.53 |
| Hair loss (n = 1,780) | 57.98 |
| Fatigue (n = 4,013) | 45.41 |
| Nausea and vomiting (n = 4,007) | 10.05 |
| Pain (n = 4,023) | 32.71 |
| Dyspnea (n = 3,962) | 28.57 |
| Sleep disturbances (n = 3,994) | 44.24 |
| Loss of appetite (n = 4,017) | 20.92a |
| Constipation (n = 3,983) | 18.08a |
| Diarrhea (n = 3,979) | 11.23a |
a
The majority of patients were not symptomatic in this category.
0 = ‘No symptoms’ refers to a score of 1 in this questionnaire; 100 = ‘very strong symptoms’ refers to a score of 4 for all symptoms in the EORTC QLQ-30.
EORTC = European Organization for Research and Treatment of Cancer.